Ferring Pharmaceuticals

This study tested whether RBX2660 (REBYOTA), a treatment for recurrent Clostridioides difficile infection, can be safely and effectively given via colonoscopy instead of the usual method. 41 adults with at least one recurrence of C. diff took part. The main goals were to check fo…

This study tested two different starting doses of the fertility drug follitropin delta against two doses of the standard drug Gonal-F in 301 Chinese women undergoing IVF. The main goal was to see how many eggs were retrieved. The trial was completed and aimed to find the best sta…

This study checked the long-term safety of the drug degarelix in 57 men with prostate cancer. Participants received the drug for up to 5 years. The main goal was to see if any serious side effects occurred, such as changes in blood pressure or liver function. The results help doc…

This study followed 145 adults who received REBYOTA™ to prevent another Clostridioides difficile infection (CDI) in everyday medical practice. Researchers tracked how many patients stayed infection-free for 6 months after treatment. The goal was to see if REBYOTA™ works well outs…

This study observed 201 women in Nordic countries and Switzerland who were using REKOVELLE® for their first IVF or ICSI treatment. Researchers tracked how doctors prescribed the drug, including dosing based on body weight and hormone levels, and looked at pregnancy rates and safe…

This study looked at medical records from over 1 million people in Denmark, Sweden, and Germany to check the safety of the drug NOCDURNA. NOCDURNA is used to treat frequent nighttime urination caused by a condition where the body makes too much urine at night. The researchers foc…